Identity
- Security key
- 13813
- Ticker
- CRVO
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1996-06-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CRVO
Detail
Enriched 2026-08-14 20:47
- Market cap
- $41,525,535.31
- Shares outstanding (class)
- 13,526,233
- Shares outstanding (weighted)
- 13,526,233
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 15
- Location
- BOSTON, MA
- Homepage
- https://www.cervomed.com
- Description
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.